Related Experiment Video
Updated: Sep 22, 2025
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.0K
Inpatient Diabetes Management.
Sumera Ahmed1, Joseph Patrick Styers2
1Primary Care Department, Diabetes Fellowship, Touro University College of Osteopathic Medicine, 1310 Club Drive, Vallejo, CA 94592, USA.
Primary Care
|May 20, 2022
Summary
Effective diabetes management in hospitals needs coordinated care and timely insulin adjustments. Communication between hospital physicians and primary care providers is crucial for patient safety and preventing adverse events.
Area of Science:
- Internal Medicine
- Endocrinology
- Hospital Management
Background:
- Hospitalized patients with diabetes require specialized management.
- Clinical status of inpatients can change rapidly, necessitating prompt treatment adjustments.
- Poor communication can lead to suboptimal glycemic control and adverse events.
Purpose of the Study:
- To highlight the importance of interdisciplinary care in managing hospitalized patients with diabetes.
- To emphasize the need for timely insulin dose adjustments.
- To underscore the critical role of communication between inpatient and primary care physicians.
Main Methods:
- Review of current best practices in inpatient diabetes management.
- Analysis of factors influencing glycemic control in hospitalized patients.
- Discussion of communication strategies between healthcare providers.
Main Results:
- Interdisciplinary, coordinated care is essential for optimal diabetes management.
- Timely insulin dosing adjustments are critical to prevent hypoglycemia and hyperglycemia.
- Effective communication bridges the gap between hospital care and primary care.
Conclusions:
- Coordinated care and clear communication are vital for safe and effective diabetes management in hospitals.
- Prompt insulin adjustments based on clinical status improve patient outcomes.
- Strengthening the link between hospital teams and primary care providers enhances continuity of care.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
420
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
420
01:22Diabetes Mellitus: Type 2 and Gestational
3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
01:22Diabetes Mellitus: Overview and Type I Subtype
3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
01:16Insulin: Dosing Regimen and Adverse Effects
281
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
281
01:15Diabetes: Symptoms, Diagnosis, and Complications
726
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
726
01:15Hypoglycemia and Glucagon
360
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
360